Work

supplementary figure 1 from Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient–Derived Xenografts and Mesothelin as a Biomarker of Tumor Response

Year: 2023
Type: supplementary-materials
Abstract: Semiquantitative assessment of mesothelin expression using H-score in mesothelioma patient derived xenografts.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361886189
Cites:
Cited by:
Related to: 10